Premium
CLINICAL APPLICATION OF AN EX‐VIVO PLATFORM TO GUIDE THE CHOICE OF DRUG COMBINATIONS IN RELAPSED/REFRACTORY LYMPHOMA; A PROSPECTIVE STUDY
Author(s) -
De Mel S,
Goh J,
Rashid M. B. M. A,
Zhang X. Y,
Jaynes P,
Liu X,
Poon L,
Chan E,
Lee J,
Chee Y. L,
Koh L. P,
Tan L. K,
Soh T. G,
Yuen Y. C,
Loi HoiY,
Ng SiokB,
Goh X,
Tan D,
Cheah D. M. Z,
Pang W. L,
Huang D,
Chan J. Y,
Somasundaram N,
Tang T,
Lim S. T,
Ong C. K,
Chng W.J,
Chow E. K,
Jeyasekharan A. D
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.147_2880
Subject(s) - medicine , lymphoma , concordance , oncology , clinical trial , prospective cohort study , interim analysis , refractory (planetary science) , drug , pharmacology , physics , astrobiology